Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome. - Vermeulen, Sim; Awada, Gil; Keyaerts, Marleen; Neyns, Bart; Everaert, Hendrik (Current Oncology, 2021)